Last reviewed · How we verify

NCT06189560: SGB

Stellate Ganglion Block: A Breakthrough Treatment for Post-Stroke Pharyngeal Dysphagia

Terminated NA Last updated 5 March 2024
What this trial tests

NA trial testing comprehensive rehabilitation in Dysphagia in 65 participants. Terminated before completion.

Timeline
21 June 2022
Primary endpoint
2 May 2023
17 May 2023

Quick facts

Lead sponsorZeng Changhao
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment65
Start date21 June 2022
Primary completion2 May 2023
Estimated completion17 May 2023
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Zeng Changhao — full company profile →

Who can join

Adults 30 to 80, any sex, with Dysphagia or Stellate Ganglion Block. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This was a multicenter randomized controlled study. 66 post-stroke patients with pharyngeal dysphagia were randomly allocated to the observation group (n=33) or the control group (n=33). Both groups were provided with comprehensive rehabilitation including routine rehabilitation and swallowing function training. Besides, the observation group additionally underwent the stellate ganglion block (SGB). At admission and after 20-day treatment, Kubota water swallowing test, video fluoroscopic swallowing study (VFSS), and Rosenbek penetration-aspiration scale (PAS) were used to assess swallowing function.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of comprehensive rehabilitation

Trials testing the same drug.

Other recruiting trials for Dysphagia

Currently open trials in the same condition.

Other Zeng Changhao trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06189560.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing